Medroxyprogesterone combined with Medroxyprogesterone Acetate

Reports:

Reaction Outcome Event Date Age Sex Weight Reported Reporter Country Treatment
Role Name
Progesterone Receptor Assay Positive Other Serious 3/21/2000 61 Female 1/20/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 1/1/2001 Female 2/1/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 2/3/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 2/6/2006 United States
Primary
Secondary
Breast Cancer Metastatic Other Serious Female 2/14/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 3/29/2002 Female 3/8/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 8/29/2000 68 Female 3/17/2006 United States
Primary
Secondary
Oestrogen Receptor Assay Positive Other Serious 7/9/1998 71 Female 3/17/2006 United States
Primary
Secondary
Breast Cancer In Situ Other Serious 5/7/1999 67 Female 3/17/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 3/13/2001 80 Female 3/28/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 5/30/2003 55 Female 4/13/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 7/3/2002 63 Female 4/13/2006 United States
Primary
Secondary
Oestrogen Receptor Assay Positive Other Serious 4/1/1999 60 Female 4/20/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/20/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 7/1/2002 Female 4/24/2006 United States
Primary
Secondary
Uterine Cancer Other Serious 1/6/2004 Female 4/26/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 12/4/2002 Female 4/26/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 5/16/2002 Female 5/3/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 5/14/2002 Female 5/4/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 5/9/2002 Female 5/4/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 6/6/2002 Female 5/5/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 1/1/1998 Female 5/8/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 1/1/2000 Female 5/8/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 1/1/2000 Female 4/28/2006 United States
Primary
Secondary
Ovarian Cancer Other Serious 1/1/2003 Female 4/28/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 1/1/2003 Female 4/28/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 4/1/2002 Female 4/28/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 12/1/1999 Female 5/9/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 9/1/2002 Female 5/9/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 3/1/2002 Female 5/9/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 1/1/2001 Female 5/9/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 2/16/2000 61 Female 5/24/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 2/1/2004 63 Female 5/24/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 10/16/2003 60 Female 5/25/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 6/1/2003 60 Female 5/30/2006 United States
Primary
Secondary
Thrombosis Other Serious 7/1/2002 Female 5/30/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 10/30/2000 Female 5/31/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 12/16/1999 Female 5/31/2006 United States
Primary
Secondary
Ovarian Cancer Other Serious 10/1/2001 Female 5/31/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 12/1/1982 Female 5/31/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 10/31/2000 Female 5/31/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 11/27/2002 59 Female 6/1/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 12/2/1998 Female 6/1/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 9/1/2000 58 Female 6/13/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 8/1/2001 76 Female 6/13/2006 United States
Primary
Secondary
Breast Cancer Other Serious 12/1/2004 74 Female 6/13/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 7/1/2002 62 Female 6/13/2006 United States
Primary
Secondary
Breast Cancer Other Serious 11/1/2002 57 Female 6/13/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2001 51 Female 6/13/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 4/1/2004 56 Female 6/13/2006 United States
Primary
Secondary
Breast Cancer Other Serious 3/25/2002 Female 6/13/2006 United States
Primary
Secondary
Breast Cancer Other Serious 2/1/2001 71 Female 6/13/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 5/1/2000 64 Female 6/13/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2001 56 Female 6/13/2006 United States
Primary
Secondary
Cerebrovascular Accident Other Serious 9/30/1998 Female 4/20/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 6/19/2002 Female 7/3/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 2/1/2002 55 Female 8/14/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 9/1/2002 58 Female 8/17/2006 Lawyer United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 9/3/1998 64 Female 8/18/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 11/26/2005 61 Female 8/23/2006 United States
Primary
Secondary
Transient Ischaemic Attack Other Serious 6/25/1998 Female 142 lb 3/9/2007 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 2/9/2000 Female 8/30/2007 Consumer United States
Primary
Secondary
Hypertension Other Serious 1/1/2002 Female 10/24/2007 Lawyer United States
Primary
Secondary
Breast Cancer Metastatic Hospitalization 12/17/1999 Female 11/2/2007 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 3/7/2002 Female 12/11/2007 Lawyer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 4/13/2000 Female 1426 lb 1/25/2008 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 4/2/2002 Female 2/15/2008 Lawyer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 3/21/2003 Female 4/4/2008 Lawyer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 7/8/1999 Female 4/14/2008 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 4/2/2002 Female 5/2/2008 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2003 Female 160 lb 5/9/2008 Lawyer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 4/4/1997 Female 5/12/2008 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 7/8/1999 Female 5/15/2008 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 7/8/1999 Female 10/21/2008 Consumer United States
Primary
Secondary
Contralateral Breast Cancer Other Serious 9/12/2000 Female 12/4/2008 Consumer United States
Primary
Secondary
Contralateral Breast Cancer Other Serious 9/12/2000 Female 12/8/2008 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 1/1/1997 Female 12/11/2008 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 1/1/1996 Female 12/16/2008 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 10/7/2002 Female 2/20/2009 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 8/16/2005 Female 2/23/2009 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 4/1/2003 Female 2/27/2009 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 12/1/2004 Female 3/24/2009 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 4/1/2000 Female 110 lb 3/27/2009 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 10/1/1999 Female 115 lb 3/30/2009 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 7/1/1999 Female 3/30/2009 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 10/1/1998 Female 138 lb 4/2/2009 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 1/1/2001 Female 130 lb 4/6/2009 Lawyer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 10/7/2002 Female 4/9/2009 Consumer United States
Primary
Secondary
Breast Cancer In Situ Other Serious 5/7/1999 Female 130 lb 4/13/2009 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 6/1/1997 Female 99 lb 5/4/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 12/1/1999 Female 130 lb 5/25/2009 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 1/1/2001 Female 5/25/2009 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 10/7/2002 Female 6/2/2009 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 2/23/2001 Female 12/9/2009 Lawyer United States
Primary
Secondary
Ovarian Cancer Metastatic Other Serious 1/1/2004 Female 12/15/2009 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 12/1/2001 58 Female 4/7/2010 Lawyer United States
Primary
Secondary
Hypertension Other Serious 1/1/2002 51 Female 4/19/2010 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2000 Female 4/26/2010 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 2/15/2002 51 Female 110 lb 4/26/2010 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 8/19/2003 65 Female 160 lb 5/6/2010 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 1/1/1999 63 Female 209 lb 5/6/2010 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 8/2/2000 60 Female 143 lb 5/6/2010 Lawyer United States
Primary
Secondary
Concomitant
Hypertension Other Serious 1/1/2002 51 Female 5/25/2010 Lawyer United States
Primary
Secondary
Hypertension Other Serious 1/1/2002 51 Female 5/28/2010 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 9/26/2000 63 Female 126 lb 4/29/2009 United States
Primary
Secondary
Concomitant
Deep Vein Thrombosis Other Serious 9/10/2003 51 Female 159 lb 4/5/2010 United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 4/1/2001 64 Female 4/5/2010 United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 2/6/2001 55 Female 4/5/2010 United States
Primary
Secondary
Breast Cancer Female Other Serious 6/12/2002 58 Female 150 lb 4/5/2010 United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 7/27/1999 59 Female 4/5/2010 United States
Primary
Secondary
Breast Cancer Female Other Serious 10/1/2007 Female 4/5/2010 United States
Primary
Secondary
Hypertension Other Serious 1/1/2002 51 Female 6/9/2010 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 7/1/2002 58 Female 134 lb 4/5/2010 United States
Primary
Secondary
Breast Cancer Female Other Serious 10/1/2002 71 Female 4/5/2010 United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 11/1/2000 44 Female 220 lb 4/5/2010 United States
Primary
Secondary
Breast Cancer Female Other Serious 2/1/2003 61 Female 152 lb 4/5/2010 United States
Primary
Secondary
Breast Cancer Female Other Serious 9/1/1999 51 Female 174 lb 4/5/2010 United States
Primary
Secondary
Breast Cancer Other Serious 8/24/2005 56 Female 165 lb 4/5/2010 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 5/21/2001 59 Female 165 lb 4/5/2010 United States
Primary
Secondary
Breast Cancer Female Other Serious 4/19/1999 54 Female 4/5/2010 United States
Primary
Secondary
Breast Cancer Female Other Serious 1/1/2000 75 Female 119 lb 4/5/2010 Consumer United States
Primary
Secondary
Concomitant
Breast Cancer Metastatic Other Serious 1/10/2000 72 Female 6/16/2010 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2003 64 Female 165 lb 4/5/2010 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/5/2010 United States
Primary
Secondary
Breast Cancer Female Other Serious 2/1/2000 52 Female 218 lb 4/5/2010 United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 7/31/2003 Female 170 lb 4/5/2010 United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 2/1/2004 83 Female 4/5/2010 United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 10/13/1999 66 Female 163 lb 4/5/2010 United States
Primary
Secondary
Concomitant
Cerebrovascular Accident Other Serious 1/12/1998 56 161 lb 4/5/2010 United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 10/31/2001 54 Female 4/5/2010 United States
Primary
Secondary
Breast Cancer Female Other Serious 1/1/1989 Female 4/5/2010 United States
Primary
Secondary
Deep Vein Thrombosis Other Serious 7/7/1995 57 Female 146 lb 4/5/2010 United States
Primary
Secondary
Breast Cancer Female Other Serious 4/1/1998 52 Female 4/5/2010 United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 12/1/2001 50 Female 128 lb 4/5/2010 United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 11/1/2001 51 Female 163 lb 4/5/2010 United States
Primary
Secondary
Breast Cancer Other Serious 2/1/1999 51 Female 4/5/2010 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 11/10/2000 48 Female 123 lb 4/5/2010 United States
Primary
Secondary
Breast Cancer Other Serious 7/1/2003 71 Female 154 lb 4/5/2010 United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 12/10/2001 61 Female 143 lb 4/5/2010 United States
Primary
Secondary
Breast Cancer Female Other Serious 10/1/2000 57 Female 161 lb 4/5/2010 United States
Primary
Secondary
Breast Cancer Female Other Serious 6/15/2001 68 Female 135 lb 4/5/2010 United States
Primary
Secondary
Breast Cancer Female Other Serious 10/11/2001 57 Female 115 lb 4/5/2010 United States
Primary
Secondary
Deep Vein Thrombosis Other Serious 3/1/2001 56 Female 4/5/2010 United States
Primary
Secondary
Breast Cancer Female Other Serious 7/1/2003 51 Female 150 lb 4/5/2010 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 1/1/2002 63 Female 110 lb 4/5/2010 United States
Primary
Secondary
Breast Cancer Female Other Serious 8/21/2002 60 Female 174 lb 4/5/2010 United States
Primary
Secondary
Breast Cancer Female Other Serious 3/22/2007 Female 143 lb 4/5/2010 United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 1/1/2003 58 Female 216 lb 4/5/2010 United States
Primary
Secondary
Breast Cancer Female Other Serious 11/13/2006 64 Female 181 lb 4/5/2010 United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 1/1/2001 74 Female 214 lb 4/5/2010 United States
Primary
Secondary

Drug Data